PNPLA6 Gene SPG39 Genetic Test sale cost 4400 AED
ALDH3A2 Gene Sjogren-Larsson Syndrome Genetic Test sale cost 4400 AED ALDH3A2 Gene Sjogren-Larsson Syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
TFG Gene SPG57 Genetic Test sale cost 4400 AED TFG Gene SPG57 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

PNPLA6 Gene SPG39 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PNPLA6 gene SPG39 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the PNPLA6 gene, which are associated with spastic paraplegia 39 (SPG39). This condition is a form of hereditary spastic paraplegia, characterized by progressive weakness and stiffness of the legs. The test is crucial for individuals showing symptoms of SPG39 or those with a family history of the condition, as it aids in confirming the diagnosis, understanding the disease progression, and making informed decisions regarding management and treatment.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient’s DNA sample to detect any genetic abnormalities present in the PNPLA6 gene. The process is conducted with high precision and accuracy, ensuring reliable results for patients and healthcare providers.

The cost of the PNPLA6 gene SPG39 genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the PNPLA6 gene. Patients seeking this test can expect a seamless and supportive experience, with guidance from skilled professionals throughout the testing process.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PNPLA6 Gene SPG39 Genetic Test

Test Name: PNPLA6 Gene SPG39 Genetic Test

Components: DNA Labs UAE offers the PNPLA6 Gene SPG39 Genetic Test at a cost of 4400.0 AED.

Sample Condition: The test requires a blood sample or extracted DNA. Alternatively, one drop of blood on an FTA Card can also be used.

Report Delivery: The test results will be delivered within 3 to 4 weeks.

Method: The PNPLA6 Gene SPG39 Genetic Test utilizes NGS (Next-Generation Sequencing) technology.

Test Type: This test is specifically designed for diagnosing neurological disorders.

Doctor: The test is conducted under the supervision of a Neurologist.

Test Department: The PNPLA6 Gene SPG39 Genetic Test is conducted in the Genetics department.

Pre Test Information: Before undergoing the PNPLA6 Gene SPG39 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with PNPLA6 Gene SPG39.

Test Details: The PNPLA6 gene is associated with hereditary spastic paraplegia type 39 (SPG39), a rare genetic disorder. SPG39 is characterized by progressive muscle weakness and stiffness in the legs, which can lead to difficulty walking. The NGS genetic testing method used in this test helps identify mutations or variations in the PNPLA6 gene that may be responsible for causing the condition. This test can confirm a diagnosis, provide information about disease progression and prognosis, and assist in genetic counseling and family planning.

Test Name PNPLA6 Gene SPG39 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PNPLA6 Gene SPG39 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PNPLA6 Gene SPG39
Test Details

The PNPLA6 gene is associated with a condition called hereditary spastic paraplegia type 39 (SPG39). SPG39 is a rare genetic disorder characterized by progressive muscle weakness and stiffness in the legs (spastic paraplegia), which can eventually lead to difficulty walking.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of SPG39, NGS genetic testing can be used to identify mutations or variations in the PNPLA6 gene that may be responsible for causing the condition. This type of testing can help confirm a diagnosis, provide information about disease progression and prognosis, and may be useful for genetic counseling and family planning purposes.

SKU: TEST-2004 Category:

Related products